Cotrimoxazole is Effective as Primary Prophylaxis for Toxoplasmic Encephalitis in HIV-infected Patients: A Case Control Study

References

• Luft B J, Remington J S. Toxoplasmic Encephalitis. J Infect Dis 1988; 157: 1–6
   PubMed Web of Science ®Google Scholar
• de Gans J, Portegies P. Neurologic complications of infection with human immunodeficiency virus type 1. Clin Neurol Neurosurg 1989; 91: 199–217
   PubMed Web of Science ®Google Scholar
• Renold C, Sugar A, Chave J-P, Perrin L, Delavelle J, Pizzoloti G. Toxoplasma encephalitis in patients with the aquired immunodeficiency syndrome. Medicine 1992; 71: 224–39
   PubMed Web of Science ®Google Scholar
• Girard P-M, Landman R, Gaudebout C, Olivares R, Saimot A G, Jelazko P. Dapsone-pyrimethamine compared with aerosolzed pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993; 328: 1514–20
   PubMed Web of Science ®Google Scholar
• Oksenhendler E, Charrreau I, Tournerie Ch, Azihary M, Carbon C, Aboulker J-P. Toxoplasmosis gondii infection in advanced HIV infection. AIDS 1994; 8: 483–7
   PubMed Web of Science ®Google Scholar
• Opravil M, Hirschel B, Lazzarin A, Heald A, Pèchere M, Rüttimann S. Once-weekly administration of Dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Clin Infect Dis 1995; 20: 531–41
   PubMed Web of Science ®Google Scholar
• Falangola M F, Petito C K. Choroid plexus infection in cerebral toxoplasmosis in AIDS patients. Neurology 1993; 43: 2035–40
   PubMed Web of Science ®Google Scholar
• Luft B J, Remington J S. Toxoplasmic Encephalitis in AIDS. Clin Infect Dis 1992; 15: 211–22
   PubMed Web of Science ®Google Scholar
• Crowe S M, Carlin J B, Stewart K I, Lucas C R, Hoy J F. Predictive value of CD4 lympfocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Aquir Immune Denfic Syndr 1991; 4: 770–6
   PubMed Web of Science ®Google Scholar
• van Leeuwen R, van den Hurk P J, Mulder J W, Roos MThL, Schellekens PThA, Reiss P, Lange J MA. Opportunistic disease as measure of Immunodeficiency in HIV Infection. Immunodeficiency in HIV infection and AIDS. EC/FERS/MRC Workshop on Immunodeficiency in HIV-I Infections, G AB Janossi, F Miedema. Karger S, Basel 1991; 54–63, 1992
   Google Scholar
• Porter S B, Sande M A. Toxoplasmosis of the central nervous system in the aquired immunodeficiency syndrome. N Engl J Med 1992; 327: 1643–8
   PubMed Web of Science ®Google Scholar
• Nicholas P, Pierone G, Lin J, Gertman A, Schechter C, Masci J (1990) Trimethoprim-sulfamethoxazole in the prevention of cerebral toxoplasmosis. VI International Conference on AIDS, San Francisco, June 20–24, 1990, Abstract ThB482
   Google Scholar
• O'Farrell N, Fitt S, Bateman N T, Welch J M, Bradbeer C (1991) Prevalence of toxoplasmosis in patients with AIDS in South London: a retrospective study. Abstracts of the VII International Conference on AIDS, FlorenceItaly, June 16–21, 1991, Abstract WB2349
   Google Scholar
• Schneider M ME, Hoepelman A IM, Eeftinck Schattekerk J KM, Nielsen T L, van der Graaf Y, Frissen P HJ. A controlled trial of aerozolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 1992; 327: 1836–41
   PubMed Web of Science ®Google Scholar
• Hardy W D, Feinberg J, Finkelstein D M, Power M E, Weili He M PH, Kaczka C. A controlled trial of trimethoprim-sul-famethoxazole or aerosolized pentamidine for secondairy prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med 1992; 327: 1842–8
   PubMed Web of Science ®Google Scholar
• Carr A, Tindall B, Brew B J, Mariott D J, Harkness J L, Penny R, Cooper D A. Low-dose Trimethoprim-sulfamethoxazole prophylaxis for toxoplasmosis encephalitis in patients with AIDS. Ann Intern Med 1992; 117: 106–11
   PubMed Web of Science ®Google Scholar
• May Th, Beuscart C, Reynes J, Marchou B, Leclercq P, Borsa Lebas F. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. J Aquir Immune Defic Syndr 1994; 7: 457–62
   PubMed Web of Science ®Google Scholar
• Schwartländer B, Horsburgh C R, Jr., Hamouda O, Skarabis H, Koch M A. Changes in the spectrum of AIDS-defining conditions and decrease in CD4+ lymphocyte counts at AIDS manifestation in Germany from 1986 to 1991. AIDS 1992; 6: 413–20
   PubMed Web of Science ®Google Scholar
• Van Delden Ch, Gabriel V, Sudre Ph, Flepp M, von Overbeck J, Hirschel B, The Swiss HIV Cohort Study. Reasons for failure of prevention of toxoplasma encephalitis. AIDS 1996; 10: 509–13
   PubMed Web of Science ®Google Scholar
• Schellekens PThA, Roos MThL, de Wolf F, Lange J MA, Miedema F. Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-I (HIV-I)-infected men. J Clin Immun 1990; 10: 121–7
   PubMed Web of Science ®Google Scholar
• Podzamczer D, Salazar A, Jiménez J, Consiglio E, Santin M, Casanova A. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann Intern Med 1995; 122: 755–61
   PubMed Web of Science ®Google Scholar
• Antinori A, Murri R, Ammassari A, De Luca A, Linzalone A, Cingolani A. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. AIDS 1995; 9: 1343–50
   PubMed Web of Science ®Google Scholar
• Veenstra J, Veugelers P J, Keet I PM, van der Ven A JAM, Miedema F, Lange J MA, Coutinho R A. Rapid disease progression in human immunodeficiency virus type l-infected individuals with adverse reactions to trimethoprim-sulpha-methoxazole prophylaxis. Clin Infect Dis 1997; 24: 936–41
   PubMed Web of Science ®Google Scholar
• Leport C, Chěne G, Morlat P, Luft B J, Rousseau F, Pueyo S. Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: A double-blind, randomized trial. I Infect Dis 1996; 173: 91–7
   PubMed Web of Science ®Google Scholar